Bone Density (DEXA) Scan

Bone Density (DEXA) Scan in Pediatrics

Key Points

  • Dual-energy X-ray absorptiometry (DEXA) is the gold standard for measuring bone mineral density (BMD) in children
  • Results must be adjusted for age, sex, height, and pubertal status
  • Z-scores, not T-scores, are used in pediatric populations
  • BMD values below -2.0 Z-score indicate low bone mass for chronologic age

Overview

DEXA scanning uses low-dose X-ray beams to measure bone mineral content (BMC) and bone mineral density (BMD). In pediatrics, it's particularly valuable due to its:

  • Low radiation exposure (0.001-0.006 mSv)
  • High precision (error rate < 1%)
  • Short scan time (5-10 minutes)
  • Ability to measure specific skeletal sites

Primary Clinical Indications

  • Chronic inflammatory conditions
    • Inflammatory bowel disease
    • Juvenile idiopathic arthritis
    • Cystic fibrosis
  • Endocrine disorders
    • Growth hormone deficiency
    • Hypogonadism
    • Type 1 diabetes
  • Immobilization
    • Cerebral palsy
    • Muscular dystrophy
    • Spinal cord injuries
  • Medications affecting bone metabolism
    • Long-term glucocorticoids
    • Anticonvulsants
    • Chemotherapy

Scan Protocol

  • Standard measurement sites:
    • Lumbar spine (L1-L4) - Primary site for children
    • Total body less head (TBLH)
    • Proximal femur (in older adolescents)
  • Patient positioning:
    • Supine position
    • Proper alignment using laser guides
    • Use of positioning devices for consistency

Quality Assurance

  • Daily phantom calibration
  • Regular technologist training
  • Motion artifact monitoring
  • Regular maintenance and calibration

Result Analysis

  • Z-score interpretation:
    • ≤ -2.0: Low bone mass for chronologic age
    • -1.9 to -1.0: Below average for age
    • -0.9 to +0.9: Average for age
    • ≥ +1.0: Above average for age
  • Essential adjustments:
    • Height-for-age Z-score
    • Bone age assessment
    • Pubertal staging
    • Body composition

Clinical Correlation

  • Assessment of fracture risk
  • Growth velocity monitoring
  • Treatment response evaluation
  • Longitudinal tracking

Technical Limitations

  • Two-dimensional nature of measurements
  • Cannot distinguish cortical from trabecular bone
  • Motion artifacts in young children
  • Size-related artifacts in small children

Clinical Considerations

  • Growth and maturation effects
  • Need for sedation in young children
  • Cost and availability
  • Radiation exposure (though minimal)


Further Reading
Powered by Blogger.